This Article argues that effective national security mandates protection against the spread of infectious diseases, which requires addressing intellectual property (IP) and technology obstacles. Without modification, IP laws can bar the manufacture of needed treatments by anyone besides the IP owner and its licensees. This Article explains how usual IP norms can frustrate public health and national security, why current proposals for a pandemic agreement are largely inadequate, as well as what countries can and should do to protect national security even if there is not adequate consensus for binding obligations in an international pandemic agreement.
Volume
2024